Overview
AARD market data
Price History
AARD price chart · 1M
- O
- 5.96
- H
- 6.02
- L
- 5.74
- C
- 5.74
- Vol
- 3,628.00
- Source
- US equities market feed
- Observed
- Sep 3, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $5.96
- Previous Close
- $5.94
- Day High
- $6.02
- Day Low
- $5.74
- 52 Week High
- $7.88
- 52 Week Low
- $3.43
- 7 Day Return
- -13.68%
- 30 Day Return
- -21.05%
- 90 Day Return
- +54.72%
- 1 Year Return
- +2.50%
- Daily Notional Volume
- $20.8K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.93 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.78 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.35 – $17.94 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $140.3M · P/B 2.68.
Company News
4 captured
Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and Hub Group, Inc. (NASDAQ: HUBG); Grabar Law Office is Investigating Claims on Your BehalfGlobenewswire Inc · Aug 27, 2026, 1:15 PM
8-K filing — Aardvark Therapeutics, Inc. (AARD)SEC EDGAR · Aug 11, 2026, 9:05 PM
Aardvark Therapeutics Q2 EPS $(0.66) Beats $(0.91) EstimateBenzinga · Aug 11, 2026, 8:55 PM
HC Wainwright & Co. Reiterates Neutral on Aardvark Therapeutics, Announces $6 Price TargetBenzinga · Jul 20, 2026, 11:20 AM